Skip to main content

CITIGROUP INC (C) Stock Forecast 2025 - AI Price Prediction & Analysis


CITIGROUP INC (C) AI Stock Price Forecast & Investment Analysis

CITIGROUP INC Stock Price Chart and Technical Analysis

Loading CITIGROUP INC interactive price chart and technical analysis...

CITIGROUP INC (C) - Comprehensive Stock Analysis & Investment Research

Deep dive into CITIGROUP INC's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about CITIGROUP INC, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For CITIGROUP INC: CITIGROUP INC operates in the Finance sector, positioning it as a large-cap market leader.

CITIGROUP INC (Stock Symbol: C) is a leading company in the Finance sector , specifically operating within the National Commercial Banks industry.

The organization employs approximately 240000 professionals worldwide .

The company has established itself as a major market leader with significant institutional backing.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing CITIGROUP INC's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For CITIGROUP INC: With $84935M in annual revenue and 10.1% net margin, the company demonstrates solid profitability.

Annual Revenue: $84935 million generating a 10.1% net profit margin .

Market Capitalization: $205979 million - Classified as a large-cap stock with institutional-grade stability.

Return on Equity (ROE): 9.5% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for CITIGROUP INC stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For CITIGROUP INC: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for CITIGROUP INC stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: CITIGROUP INC's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For CITIGROUP INC: Strong free cash flow generation demonstrates exceptional operational efficiency.

CITIGROUP INC strategically competes in the highly dynamic National Commercial Banks marketplace, positioning itself as a dominant large-cap market leader with significant competitive moats and institutional investor confidence .

The company demonstrates robust operational efficiency through strong free cash flow generation of $19989 million annually, complemented by impressive 35.7% year-over-year cash flow growth.

The company maintains a healthy 19.3% gross margin, indicating strong pricing power and operational efficiency.

CITIGROUP INC (C) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for CITIGROUP INC stock analysis.

Loading CITIGROUP INC comprehensive fundamental analysis and insider trading data...

Deep dive into CITIGROUP INC's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if CITIGROUP INC stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For CITIGROUP INC: With a P/E ratio of 14.02, the market sees the stock as potentially undervalued.

P/E Ratio 14.02x
P/B Ratio 0.97x
Market Cap $205979M
Dividend Yield 0.61%
EPS $6.87
Book Value/Share $112.60
Revenue/Share $44.90
FCF/Share $-1.42
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently CITIGROUP INC converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For CITIGROUP INC: An ROE of 9.5% indicates room for improvement in shareholder value creation.

ROE 9.5%
ROA 0.7%
ROIC 5.7%
Gross Margin 19.3%
Operating Margin 13.7%
Net Margin 10.1%
EBT Margin 31.4%
Tax Rate 18.1%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess CITIGROUP INC's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For CITIGROUP INC: A current ratio of 1.72 shows adequate liquidity.

Current Ratio 1.72x
Quick Ratio 1.16x
D/E Ratio 1.42x
Financial Leverage 13.40x
Interest Coverage 3.4x
Working Capital $309M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal CITIGROUP INC's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For CITIGROUP INC: Free cash flow of $19989M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $24507M
Free Cash Flow $19989M
Capital Spending $-4518M
OCF Growth YoY 35.7%
FCF Growth YoY 40.1%
FCF/Sales 28.0%
CapEx/Sales 6.3%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively CITIGROUP INC uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For CITIGROUP INC: An asset turnover of 0.03x suggests room for improvement in asset utilization.

Asset Turnover 0.03x
Receivables Turnover 14.9x
Inventory Turnover 10.9x
Fixed Assets Turnover 0.5x
Days Sales Outstanding 24 days
Days Inventory 34 days
Payables Period 50 days
Cash Conversion Cycle 8 days
Understanding Financial Statement Data

What these metrics mean: Key figures from CITIGROUP INC's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For CITIGROUP INC: With annual revenue of $84935M, CITIGROUP INC operates at significant scale.

Income Statement ($ Millions)
Total Revenue $84935M
Operating Income $559M
SG&A Expense $39M
Cost of Goods Sold $79M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 10%
Cash & Short-term Investments 22%
Total Liabilities 92%
Short-term Debt 1%
Accounts Receivable 4%
Inventory 3%
Dividend & Shareholder Information
Dividends Per Share $0.59
Shares Outstanding 1892M
Growth Metrics (YoY)
EPS Growth 4.1%

Latest CITIGROUP INC Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting CITIGROUP INC (C) stock price and investment outlook.

, source: Insider Monkey on MSN.com

Citigroup Inc. (NYSE:C) is one of the best dividend stocks in the financial sector. On November 24, Morgan Stanley analyst ...

, source: Insider Monkey

We recently published a list of 10 Best DRIP Stocks To Own Now. In this article, we are going to take a look at where Citigroup Inc. (NYSE:C) stands against other best DRIP stocks to own now. Dividend ...

CITIGROUP INC Competitors & Peer Analysis - Finance Sector

Comparative analysis of CITIGROUP INC against industry peers and competitors in the Finance sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ALRS Unlock Forecast - 30 Days FREE Trial $561M 11.1x 1.0x
AMJB Unlock Forecast - 30 Days FREE Trial $86819M 1.4x 0.2x
AMTB Unlock Forecast - 30 Days FREE Trial $810M 12.2x 0.9x
AROW Unlock Forecast - 30 Days FREE Trial $511M 14.9x 1.2x
ASRV Unlock Forecast - 30 Days FREE Trial $51M 13.5x 0.5x
ATLO Unlock Forecast - 30 Days FREE Trial $196M 12.3x 1.0x
BAC Unlock Forecast - 30 Days FREE Trial $395422M 13.3x 1.3x
BAC-PB Unlock Forecast - 30 Days FREE Trial $184555M 6.8x 0.6x
BAC-PE Unlock Forecast - 30 Days FREE Trial $145269M 5.7x 0.5x
BAC-PK Unlock Forecast - 30 Days FREE Trial $182283M 6.6x 0.6x
BAC-PL Unlock Forecast - 30 Days FREE Trial $9161777M 336.6x 30.1x
BAC-PM Unlock Forecast - 30 Days FREE Trial $161610M 6.1x 0.5x
BAC-PN Unlock Forecast - 30 Days FREE Trial $152965M 5.7x 0.5x
BAC-PO Unlock Forecast - 30 Days FREE Trial $131710M 4.9x 0.4x
BAC-PP Unlock Forecast - 30 Days FREE Trial $124307M 4.6x 0.4x
BAC-PQ Unlock Forecast - 30 Days FREE Trial $127385M 4.8x 0.4x
BAC-PS Unlock Forecast - 30 Days FREE Trial $142191M 5.4x 0.5x
BACRP Unlock Forecast - 30 Days FREE Trial $1671108M 57.8x 5.5x
BANC Unlock Forecast - 30 Days FREE Trial $2881M 13.8x 0.8x
BANC-PF Unlock Forecast - 30 Days FREE Trial $3765M 24.7x 1.1x
BANF Unlock Forecast - 30 Days FREE Trial $3645M 15.3x 2.0x
BANFP Unlock Forecast - 30 Days FREE Trial $876M 3.7x 0.5x
BCAL Unlock Forecast - 30 Days FREE Trial $639M 13.7x 1.1x
BFC Unlock Forecast - 30 Days FREE Trial $1275M 18.1x 2.0x
BHRB Unlock Forecast - 30 Days FREE Trial $1006M 9.4x 1.2x
BML-PG Unlock Forecast - 30 Days FREE Trial $140505M 5.4x 0.5x
BML-PH Unlock Forecast - 30 Days FREE Trial $140871M 5.4x 0.5x
BML-PJ Unlock Forecast - 30 Days FREE Trial $146222M 5.6x 0.5x
BML-PL Unlock Forecast - 30 Days FREE Trial $140725M 5.4x 0.5x
BOKF Unlock Forecast - 30 Days FREE Trial $8935M 16.6x 1.5x
C Unlock Forecast - 30 Days FREE Trial $205979M 14.0x 1.0x
CAC Unlock Forecast - 30 Days FREE Trial $719M 12.6x 1.1x
CARE Unlock Forecast - 30 Days FREE Trial $426M 13.3x 1.0x
CASH Unlock Forecast - 30 Days FREE Trial $1742M 24.8x 2.0x
CBKM Unlock Forecast - 30 Days FREE Trial $73M x 0.9x
CBNA Unlock Forecast - 30 Days FREE Trial $208M 14.7x 1.3x
CBNK Unlock Forecast - 30 Days FREE Trial $467M 9.4x 1.2x
CBU Unlock Forecast - 30 Days FREE Trial $3101M 15.1x 1.6x
CFBK Unlock Forecast - 30 Days FREE Trial $151M 8.4x 0.8x
CFNB Unlock Forecast - 30 Days FREE Trial $234M 47.0x 1.2x
CFR Unlock Forecast - 30 Days FREE Trial $8119M 12.7x 1.8x
CFR-PB Unlock Forecast - 30 Days FREE Trial $1147M 1.9x 0.3x
CHCO Unlock Forecast - 30 Days FREE Trial $1779M 13.9x 2.2x
CMA Unlock Forecast - 30 Days FREE Trial $11020M 15.4x 1.3x
CMTV Unlock Forecast - 30 Days FREE Trial $138M 17.9x 1.2x
COF Unlock Forecast - 30 Days FREE Trial $146651M 103.6x 1.3x
COF-PI Unlock Forecast - 30 Days FREE Trial $12162M x 0.1x
COF-PJ Unlock Forecast - 30 Days FREE Trial $11570M x 0.1x
COF-PK Unlock Forecast - 30 Days FREE Trial $11252M x 0.1x
COF-PL Unlock Forecast - 30 Days FREE Trial $10585M x 0.1x
COF-PN Unlock Forecast - 30 Days FREE Trial $10477M x 0.1x
C-PN Unlock Forecast - 30 Days FREE Trial $57132M 4.2x 0.3x
DCOM Unlock Forecast - 30 Days FREE Trial $1312M 22.5x 0.9x
DCOMG Unlock Forecast - 30 Days FREE Trial $1146M 26.1x 0.8x
DCOMP Unlock Forecast - 30 Days FREE Trial $824M 18.9x 0.6x
ENBP Unlock Forecast - 30 Days FREE Trial $126M 6.5x 0.8x
FCF Unlock Forecast - 30 Days FREE Trial $1731M 12.1x 1.1x
FDBC Unlock Forecast - 30 Days FREE Trial $253M 9.7x 1.1x
FFBC Unlock Forecast - 30 Days FREE Trial $2469M 9.6x 0.9x
FHN Unlock Forecast - 30 Days FREE Trial $11742M 13.3x 1.3x
FHN-PC Unlock Forecast - 30 Days FREE Trial $13076M 15.4x 1.5x
FHN-PE Unlock Forecast - 30 Days FREE Trial $12671M 15.2x 1.4x
FHN-PF Unlock Forecast - 30 Days FREE Trial $9508M 11.2x 1.1x
FIISO Unlock Forecast - 30 Days FREE Trial $2721M x 4.4x
FISI Unlock Forecast - 30 Days FREE Trial $630M 8.1x 1.0x
FMCB Unlock Forecast - 30 Days FREE Trial $778M 8.5x 1.2x
FNB Unlock Forecast - 30 Days FREE Trial $6127M 12.1x 0.9x
FNLC Unlock Forecast - 30 Days FREE Trial $290M 9.2x 1.1x
FRME Unlock Forecast - 30 Days FREE Trial $2150M 9.2x 0.9x
FRMEP Unlock Forecast - 30 Days FREE Trial $1476M 6.7x 0.6x
FSUN Unlock Forecast - 30 Days FREE Trial $985M 11.0x 0.9x
FULT Unlock Forecast - 30 Days FREE Trial $3491M 9.7x 1.0x
FULTP Unlock Forecast - 30 Days FREE Trial $3568M 11.2x 1.0x
FUNC Unlock Forecast - 30 Days FREE Trial $251M 10.1x 1.3x
GNTY Unlock Forecast - 30 Days FREE Trial $553M 15.3x 1.7x
HAFC Unlock Forecast - 30 Days FREE Trial $840M 11.6x 1.1x
HBAN Unlock Forecast - 30 Days FREE Trial $24664M 11.1x 1.1x
HBANL Unlock Forecast - 30 Days FREE Trial $37652M 17.5x 1.7x
HBANM Unlock Forecast - 30 Days FREE Trial $32471M 16.0x 1.5x
HBANP Unlock Forecast - 30 Days FREE Trial $25116M 12.7x 1.1x
HOPE Unlock Forecast - 30 Days FREE Trial $1401M 29.0x 0.6x
HWBK Unlock Forecast - 30 Days FREE Trial $239M 10.7x 1.5x
JPM Unlock Forecast - 30 Days FREE Trial $880600M 15.2x 2.4x
JPM-PC Unlock Forecast - 30 Days FREE Trial $70523M 1.3x 0.2x
JPM-PD Unlock Forecast - 30 Days FREE Trial $69964M 1.3x 0.2x
JPM-PJ Unlock Forecast - 30 Days FREE Trial $56882M 1.1x 0.2x
JPM-PK Unlock Forecast - 30 Days FREE Trial $54423M 1.0x 0.2x
JPM-PL Unlock Forecast - 30 Days FREE Trial $55373M 1.0x 0.2x
JPM-PM Unlock Forecast - 30 Days FREE Trial $51012M 1.0x 0.1x
KEY Unlock Forecast - 30 Days FREE Trial $21347M 19.9x 1.1x
KEY-PI Unlock Forecast - 30 Days FREE Trial $27433M 157.7x 1.4x
KEY-PJ Unlock Forecast - 30 Days FREE Trial $24052M 139.9x 1.2x
KEY-PK Unlock Forecast - 30 Days FREE Trial $23581M 139.7x 1.2x
KEY-PL Unlock Forecast - 30 Days FREE Trial $28020M 157.7x 1.4x
LARK Unlock Forecast - 30 Days FREE Trial $169146M 9321.4x 1086.2x
LCNB Unlock Forecast - 30 Days FREE Trial $227M 9.6x 0.8x
MER-PK Unlock Forecast - 30 Days FREE Trial $189612M 6.9x 0.6x
MFG Unlock Forecast - 30 Days FREE Trial $18598M x 0.0x
MRBK Unlock Forecast - 30 Days FREE Trial $184M 9.5x 1.0x
MZHOF Unlock Forecast - 30 Days FREE Trial $87168M x 0.0x
NBHC Unlock Forecast - 30 Days FREE Trial $1460M 12.0x 1.1x
NBTB Unlock Forecast - 30 Days FREE Trial $2095M 14.0x 1.1x
NEWT Unlock Forecast - 30 Days FREE Trial $326M 5.5x 0.8x
NEWTG Unlock Forecast - 30 Days FREE Trial $722M 12.3x 1.9x
NEWTH Unlock Forecast - 30 Days FREE Trial $724M 12.2x 1.9x
NEWTI Unlock Forecast - 30 Days FREE Trial $733M 12.5x 1.9x
NEWTZ Unlock Forecast - 30 Days FREE Trial $722M 12.2x 1.9x
NIC Unlock Forecast - 30 Days FREE Trial $1914M 13.2x 1.6x
NKSH Unlock Forecast - 30 Days FREE Trial $190M 14.6x 1.1x
NWBI Unlock Forecast - 30 Days FREE Trial $1803M 16.0x 1.0x
OCFC Unlock Forecast - 30 Days FREE Trial $1116M 14.0x 0.7x
ONB Unlock Forecast - 30 Days FREE Trial $8714M 14.4x 1.1x
ONBPO Unlock Forecast - 30 Days FREE Trial $9782M 17.4x 1.2x
ONBPP Unlock Forecast - 30 Days FREE Trial $9750M 17.3x 1.2x
OPHC Unlock Forecast - 30 Days FREE Trial $49M 3.2x 0.4x
PFIS Unlock Forecast - 30 Days FREE Trial $497M 9.3x 1.0x
PNFP Unlock Forecast - 30 Days FREE Trial $7444M 11.9x 1.1x
PNFPP Unlock Forecast - 30 Days FREE Trial $1939M 3.3x 0.3x
PRK Unlock Forecast - 30 Days FREE Trial $2568M 14.6x 2.3x
RF Unlock Forecast - 30 Days FREE Trial $23705M 11.0x 1.2x
RF-PC Unlock Forecast - 30 Days FREE Trial $21395M 10.7x 1.1x
RF-PE Unlock Forecast - 30 Days FREE Trial $15544M 8.0x 0.8x
RF-PF Unlock Forecast - 30 Days FREE Trial $22884M 11.1x 1.2x
SFNC Unlock Forecast - 30 Days FREE Trial $2719M 14.1x 0.8x
SFST Unlock Forecast - 30 Days FREE Trial $430M 16.1x 1.2x
SHBI Unlock Forecast - 30 Days FREE Trial $590M 10.4x 1.0x
SMBK Unlock Forecast - 30 Days FREE Trial $632M 13.7x 1.2x
SNNF Unlock Forecast - 30 Days FREE Trial $18M x 0.7x
SNV Unlock Forecast - 30 Days FREE Trial $7010M 8.8x 1.2x
SNV-PD Unlock Forecast - 30 Days FREE Trial $3523M 4.5x 0.6x
SNV-PE Unlock Forecast - 30 Days FREE Trial $3665M 4.8x 0.6x
STEL Unlock Forecast - 30 Days FREE Trial $1638M 16.1x 1.0x
TBBK Unlock Forecast - 30 Days FREE Trial $2923M 12.8x 3.8x
TRMK Unlock Forecast - 30 Days FREE Trial $2388M 10.7x 1.1x
UBFO Unlock Forecast - 30 Days FREE Trial $175M 15.4x 1.3x
UBOH Unlock Forecast - 30 Days FREE Trial $106M 10.1x 1.3x
UMBF Unlock Forecast - 30 Days FREE Trial $8730M 14.4x 1.2x
UMBFO Unlock Forecast - 30 Days FREE Trial $2030M 3.8x 0.3x
USB Unlock Forecast - 30 Days FREE Trial $79914M 11.1x 1.3x
USB-PA Unlock Forecast - 30 Days FREE Trial $1225951M 183.6x 19.4x
USB-PH Unlock Forecast - 30 Days FREE Trial $28639M 4.3x 0.5x
USB-PP Unlock Forecast - 30 Days FREE Trial $35670M 5.4x 0.6x
USB-PQ Unlock Forecast - 30 Days FREE Trial $23806M 3.6x 0.4x
USB-PR Unlock Forecast - 30 Days FREE Trial $25646M 3.8x 0.4x
USB-PS Unlock Forecast - 30 Days FREE Trial $28701M 4.4x 0.5x
VABK Unlock Forecast - 30 Days FREE Trial $219M 12.3x 1.2x
VLY Unlock Forecast - 30 Days FREE Trial $6513M 12.6x 0.9x
VLYPN Unlock Forecast - 30 Days FREE Trial $14690M 32.1x 1.9x
VLYPO Unlock Forecast - 30 Days FREE Trial $14291M 31.1x 1.9x
VLYPP Unlock Forecast - 30 Days FREE Trial $14239M 31.3x 1.9x
VYLD Unlock Forecast - 30 Days FREE Trial $76250M 1.3x 0.2x
WABC Unlock Forecast - 30 Days FREE Trial $1209M 10.1x 1.3x
WAFD Unlock Forecast - 30 Days FREE Trial $2518M 11.1x 0.8x
WAFDP Unlock Forecast - 30 Days FREE Trial $1310M 5.8x 0.4x
WBHC Unlock Forecast - 30 Days FREE Trial $2123M 33.3x 3.8x
WBS Unlock Forecast - 30 Days FREE Trial $10299M 11.1x 1.1x
WBS-PF Unlock Forecast - 30 Days FREE Trial $3211M 4.0x 0.3x
WBS-PG Unlock Forecast - 30 Days FREE Trial $3942M 4.8x 0.4x
WFC Unlock Forecast - 30 Days FREE Trial $282866M 13.4x 1.6x
WFCNP Unlock Forecast - 30 Days FREE Trial $4723M 0.3x 0.0x
WFC-PA Unlock Forecast - 30 Days FREE Trial $59735M 3.1x 0.3x
WFC-PC Unlock Forecast - 30 Days FREE Trial $55736M 2.9x 0.3x
WFC-PD Unlock Forecast - 30 Days FREE Trial $53941M 2.8x 0.3x
WFC-PL Unlock Forecast - 30 Days FREE Trial $3846381M 195.1x 21.2x
WFC-PY Unlock Forecast - 30 Days FREE Trial $75479M 3.9x 0.4x
WFC-PZ Unlock Forecast - 30 Days FREE Trial $60648M 3.1x 0.3x
WSBC Unlock Forecast - 30 Days FREE Trial $3139M 17.3x 0.8x
WSBCP Unlock Forecast - 30 Days FREE Trial $2400M 18.0x 0.6x
WSFS Unlock Forecast - 30 Days FREE Trial $3203M 11.5x 1.2x
ZION Unlock Forecast - 30 Days FREE Trial $8187M 9.6x 1.2x
ZIONP Unlock Forecast - 30 Days FREE Trial $3157M 3.8x 0.5x

Frequently Asked Questions - CITIGROUP INC Stock Forecast

How accurate are CITIGROUP INC stock predictions?

Our AI model shows a 5% Spearman correlation coefficient for C predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence CITIGROUP INC stock price forecasts?

Our analysis considers CITIGROUP INC's financial metrics, Finance sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is CITIGROUP INC a good investment in 2025?

Based on our AI analysis, CITIGROUP INC shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are CITIGROUP INC forecasts updated?

CITIGROUP INC stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced CITIGROUP INC Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for CITIGROUP INC stock.

My Portfolio

Investment Dashboard

Loading your portfolio...